Abstract 14 Omidubicel-Onlv: Robustness of the Manufacturing Process

INTRODUCTION: Omidubicel-onlv is a nicotinamide (NAM) -modified allogeneic hematopoietic progenitor cell therapy derived from cord blood. NAM expansion increases the number of stem and progenitor cells, inhibits differentiation, and potentiates migration, bone marrow homing, and engraftment efficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Landau, Efrat, Goudsmid-Rosenheimer, Noga, Hasson, Nira, Bengaiev, Roman, Guttman, Miri, Yaacobov, Liat, Nuriel, Yonatan, Geffen, Yona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cord Blood Collection, Manufacturing and Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476960/
http://dx.doi.org/10.1093/stcltm/szad047.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476960/
http://dx.doi.org/10.1093/stcltm/szad047.015

Ejemplares similares